Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration.
Teo KYC, Eldem B, Joussen A, Koh A, Korobelnik JF, Li X, Loewenstein A, Lövestam-Adrian M, Navarro R, Okada AA, Pearce I, Rodríguez F, Wong D, Wu L, Zur D, Zarranz-Ventura J, Mitchell P, Chaudhary V, Lanzetta P. Teo KYC, et al. Among authors: mitchell p. Eye (Lond). 2024 Oct 8. doi: 10.1038/s41433-024-03370-0. Online ahead of print. Eye (Lond). 2024. PMID: 39379523 Review.
XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration.
Korobelnik JF, Chaudhary V, Mitchell P, Kang SW, Tadayoni R, Allmeier H, Lee J, Zhang X, Machewitz T, Bailey C. Korobelnik JF, et al. Among authors: mitchell p. Ophthalmol Ther. 2024 Mar;13(3):725-738. doi: 10.1007/s40123-023-00867-x. Epub 2024 Jan 10. Ophthalmol Ther. 2024. PMID: 38198053 Free PMC article.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic Staff.
Ziemssen F, Sylvanowicz M, Amoaku WM, Aslam T, Eldem B, Finger RP, Gale RP, Kodjikian L, Korobelnik JF, Lin X, Loewenstein A, Mitchell P, Murphy M, Owens DR, Parker N, Pearce I, Rodríguez FJ, Stern J, Talks SJ, Wong DT, Wong TY, Barratt J. Ziemssen F, et al. Among authors: mitchell p. Ophthalmol Ther. 2025 Jan;14(1):229-246. doi: 10.1007/s40123-024-01060-4. Epub 2024 Dec 14. Ophthalmol Ther. 2025. PMID: 39673039 Free PMC article.
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration.
Loewenstein A, Sylvanowicz M, Amoaku WM, Aslam T, Cheung CMG, Eldem B, Finger RP, Gale RP, Kodjikian L, Koh A, Korobelnik JF, Lin X, Mitchell P, Murphy M, Okada M, Pearce I, Rodriguez FJ, Stern J, Talks SJ, Wong DT, Wong TY, Ziemssen F, Barratt J. Loewenstein A, et al. Among authors: mitchell p. Ophthalmol Ther. 2025 Jan;14(1):211-228. doi: 10.1007/s40123-024-01061-3. Epub 2024 Dec 14. Ophthalmol Ther. 2025. PMID: 39673040 Free PMC article.
4,423 results